Adamas Pharmaceuticals, Inc. (ADMS) Earnings
|
Expand Research on ADMS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/21 |  |
Q221 | -$0.27 | -$0.29 | +$0.02 | $22M | $21.95M | N/A |  | | Details |
| 5/10/21 | |
Q121 | -$0.36 | -$0.51 | +$0.15 | $19.3M | $20.02M | N/A | | | Details |
| 2/23/21 | |
Q420 | -$0.64 | -$0.51 | -$0.13 | $21M | $20.96M | N/A | | | Details |
3/4/19  |
Q118 | -$1.06 | N/A | N/A | $13.3M | $568K | N/A | | | Details | |
| 2/22/18 | |
Q417 | -$1.27 | -$1.18 | -$0.09 | $568K | $840K | = | | | Details |
| 11/2/17 | |
Q317 | -$1.04 | -$0.98 | -$0.06 | N/A | $30K | = | | | Details |
| 8/8/17 | Q217 | -$0.93 | -$0.81 | -$0.12 | N/A | $40K | = | | | Details | |
| 5/9/17 | |
Q117 | -$0.72 | -$0.71 | -$0.01 | N/A | $230K | = | | | Details |
